UK hospitals urged to embrace intensity-modulated radiotherapy
This article was originally published in Clinica
Executive Summary
Cancer Research UK (CRUK) is calling on hospitals to replace conventional radiotherapy with intensity-modulated radiotherapy (IMRT) as the standard form of treatment of cancers of the head and neck. Citing the results of research presented today at the National Cancer Research Institute (NCRI) Conference, in Birmingham, it highlighted the "more accurate targeting [by IMRT] of effective radiotherapy doses to the tumour, while reducing damage to healthy organs".
You may also be interested in...
Pharma Can Pursue Claims Against Providers For 340B Duplicate Discounts In Medicaid Managed Care, HRSA Says
The statement, which is part of a final rule on the 340B administrative dispute resolution process, could facilitate manufacturer efforts to seek repayments from hospitals in such cases.
The Aspirin Test For AI?
US FDA Commissioner Robert Califf tells Congress that regulators don’t have to know how artificial intelligence works in medicine, but must make very sure it actually does work.
Mary Beth Clarke, CDER Exec Programs Office Director And Generic User Fee Shepherd, Will Retire
Clarke helped launch GDUFA I and negotiate GDUFA II, chaired the CDER Executive Committee and oversaw many other programs in the US FDA’s drugs center.